Industry Advisory Council

Chair

Todd Vienneau, Director, Business Development, New Growth Opportunities, GlaxoSmithKline

Members

Mark Lundie, Director, Research and Development, Pfizer Canada Inc.

Doron Sagman, Vice President, Research and Development, Eli Lilly

Pat Horgan, Vice President, Manufacturing and Development, Smarter Planet, IBM

Don Aldridge, GM, Research and Life Sciences, IBM Canada Ltd.

John Andrews, President and Chief Scientific Officer, Neuraxon Inc.

Greg Molnar, Director, Neuromodulation Research Research (US), Medtronic

Genevieve Lavertu, Director, Legal, Scientific Affairs and Business Development, Medtronic of Canada Ltd.

Anne Vivian-Scott, President and CEO, BKIN Technologies

John Soloninka, President and CEO, Health Technologies Exchange

Stuart Raper, Strategic Marketing Manager - Neuroscience (UK), GE Healthcare

Cynthia Stewart, Manager, Academic Partnerships, GE Healthcare